The health monitoring software provider, which counts iFlytek as an investor, has received $78.2m in a round led by Huaxing Growth Capital.
Hangzhou Jianhai Technology, a China-based healthcare management software provider that counts artificial intelligence technology provider iFlytek as an investor, has raised RMB500m ($78.2m) in series B-plus funding, DealStreetAsia has reported.
Investment bank China Renaissance’s Huaxing Growth Capital subsidiary led the round, which was filled out by 3H Health Investment, Guoce Investment and Sequoia Capital China.
Founded in 2015, Jianhai has developed an artificial intelligence (AI) software platform that monitors patients once they leave hospital. It will use the funding to…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
